Study of Neurological Damage From Coronavirus Disease (COVID-19)

• Conditions: COVID-19

• Registration Number: NCT05079373
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

The objective of this study is to support the exploration of the NEURO-COVID-19 database and in particular to carry out the post-treatments necessary to derive quantitative information on the characterization of the lesion load, in particular with regard to of the vascular tree

Detailed Description

Not available

Study Timeline

• Study Start: 2021-04-01
• Status Verified: 2021-10
• Study First Submitted: 2021-10-13
• Study First Submitted QC: 2021-10-13
• Study First Posted: 2021-10-15
• Last Update Submitted: 2021-11-17
• Last Update Posted: 2021-11-30
• Primary Completion: 2022-10-09
• Study Completion: 2022-10-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Retrospective study of the neurological damage in patients with Covid-19	Files analysed retrospectively from January 01, 2020 to October 31, 2021 will be examined]

Trial Locations

Locations (1)

Service d'Imagerie 2 - Neuroradiologie et Radiologie Ostéo-articulaire - Hôpitaux Universitaires de Strasbourg; 🇫🇷 Strasbourg, France